Standard dose escalation The typical semaglutide dose escalation schedule follows this pattern: Weeks 1-4: 0.25mg once weekly Weeks 5-8: 0.5mg once weekly Weeks 9-12: 1.0mg once weekly Weeks 13-16: 1.7mg once weekly Week 17 onward: 2.4mg once weekly (maintenance dose for weight management) This escalation exists for a reason
The combination of attenuated early release and enhanced cumulative release supports a dual function of methionine in suppressing burst release while promoting prolonged delivery
As an aside and earlier stage, Regeneron are interested in understanding obesity as a heterogeneous disease and, through the Regeneron Genetic Center, finding and developing novel genetic targets for obesity
Like all medications, GLP-1 drugs can cause side effects, including nausea, vomiting, diarrhea, and constipation
The ingredients or doses could be completely different from what the label says, and the product could be contaminated